Evidence map›Paper›PMID 34104436›Full record

ReviewSAGE open medicine2021

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.

Kevin Y Wang, James Newman, Chung-Shien Lee, Nagashree Seetharamu

Open access · goldAbstract readReview
In one paragraph

Review in SAGE open medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kevin Y WangDepartment of Internal Medicine, Northshore University Hospital, Manhasset, NY, USA.ORCID https://orcid.org/0000-0002-7509-6989
James NewmanDepartment of Hematology Oncology, Northshore University Hospital, Manhasset, NY, USA.
Chung-Shien LeeSt. John's University College of Pharmacy and Health Sciences, Queens, NY, USA.ORCID https://orcid.org/0000-0003-3505-6402
Nagashree SeetharamuDepartment of Hematology Oncology, Northshore University Hospital, Manhasset, NY, USA.
North Shore University Hospital · USSt. John's University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common malignancy in women, and lung cancer, the leading cause of cancer-related mortality in the United States, is the most common subsequent primary cancer among breast cancer survivors. In this review, we examine the risk factors that cause subsequent primary lung cancer after breast cancer (referred to herein as BCLC patients) as well as the prognostic factors that may affect survival. Notable clinicopathological features include patient characteristics such as age, smoking history, and the presence of

Indexed as

BRCABreast cancerchemotherapyEGFRestrogen receptor (ER)HER2 receptorlung cancerprogesterone receptor (PR)radiationsurgeryTP53

Identifiers

PMID34104436
PMCPMC8155786
OpenAlexW3165865991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.